Quantum biopharma closes private placement offering

Toronto, ontario--(newsfile corp. - september 13, 2024) - quantum biopharma ltd. (nasdaq: qntm) (cse: qntm) (fse: 0k9) ("quantum biopharma" or the "company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that, further to its press release dated september 6, 2024 (the "september 6 th press release"), as approved by the shareholders of the company at the annual general and special meeting of shareholders held on july 22, 2024, the company has closed a non-brokered private placement and issued 6 class a multiple voting shares of the company ("class a shares") at a price of $6.00 per class a share for gross proceeds of $36.00 (the "offering").
QNTM Ratings Summary
QNTM Quant Ranking